Results 11 to 20 of about 499,895 (395)

Obstructive Cardiomyopathy [Abridged] [PDF]

Proceedings of the Royal Society of Medicine, 1964
J F Goodwin
  +16 more sources

Impact of cibenzoline treatment on left ventricular remodelling and prognosis in hypertrophic obstructive cardiomyopathy

ESC Heart Failure, 2021
This study aimed to elucidate the long‐term effect of cibenzoline therapy on cardiovascular complications and prognosis in patients with hypertrophic obstructive cardiomyopathy (HOCM).
M. Hamada, Y. Shigematsu, S. Ikeda, K. Ohshima, A. Ogimoto   +4 more
semanticscholar   +1 more source

Efficacy and safety of mavacamten in treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis

Future Science OA, 2023
Aim: This meta-analysis was performed to assess the efficacy and safety of mavacamten in patients with hypertrophic cardiomyopathy. Methods & materials: A search was conducted using PubMed, Cochrane, and Scopus up to August 2022 for randomized studies ...
Areeba Memon, Muhammad Omar Larik, Zoha Khan, Maryam Urooj, Areeka Irfan, Beena Kumari, Mehak Faisal, Rida Siddiqui, Moniba Tehrim, Ishaque Hameed   +9 more
doaj   +1 more source

Age‐related survival after alcohol septal ablation in hypertrophic obstructive cardiomyopathy

ESC Heart Failure, 2021
Since its introduction, alcohol septal ablation (PTSMA) was discussed as treatment option only in elderly symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM). We report on long‐term follow‐up after PTSMA with respect to patient's age.
A. Batzner, D. Aicha, B. Pfeiffer, Anna Neugebauer, H. Seggewiss   +4 more
semanticscholar   +1 more source

Echocardiography for hypertrophic obstructive cardiomyopathy

Annals of Cardiac Anaesthesia, 2017
Kalpna Irpachi, K Ashok Kumar, Poonam Malhotra Kapoor   +2 more
doaj   +3 more sources

Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Information on impact of race and ethnicity on use and early outcomes of septal reduction therapies (SRTs) for obstructive hypertrophic obstructive cardiomyopathy are limited.
Sri Harsha Patlolla, Hartzell V. Schaff, Rick A. Nishimura, Mackram F. Eleid, Jeffrey B. Geske, Steve R. Ommen   +5 more
doaj   +1 more source

Evidence of evolution towards left midventricular obstruction in severe Anderson–Fabry cardiomyopathy

ESC Heart Failure, 2021
Aims In Fabry cardiomyopathy, left ventricular outflow tract obstruction mimicking hypertrophic cardiomyopathy is a very rare finding, with few cases reported and successfully treated with cardiac surgery. In our population of patients with Fabry disease
Francesca Graziani, Rosa Lillo, Elena Panaioli, Gionata Spagnoletti, Maurizio Pieroni, Paolo Ferrazzi, Antonia Camporeale, Elena Verrecchia, Ludovico Luca Sicignano, Raffaele Manna, Filippo Crea   +10 more
doaj   +1 more source

Mega Coronary Arteries with Obstructive Coronary Artery Disease in Hypertrophic Obstructive Cardiomyopathy: A Case Report and Literature Review

Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2022
We report a rare case of hypertrophic obstructive cardiomyopathy (HOCM) presenting with mega coronary arteries with obstructive coronary artery disease.
Debasish Das, Debasis Acharya, Tutan Das, Subhas Pramanik   +3 more
doaj   +1 more source

Unveiling the Hidden Patterns: Multimodality Cardiac Imaging in Takotsubo Cardiomyopathy Diagnosis

Methodist DeBakey Cardiovascular Journal, 2023
Takotsubo cardiomyopathy, also known as stress cardiomyopathy, is a reversible form of cardiomyopathy characterized by reduced ejection fraction with regional wall motion abnormalities, elevated cardiac enzyme levels, and signs of ischemia on ...
Moath Said Alfawara, Mahmoud Al Rifai, Malek Nayfeh, Mohammed A. R. Chamsi-Pasha, Mouaz H. Al-Mallah   +4 more
doaj   +1 more source

Left ventricular myocardial strain and electrocardiographic changes in children with hypertrophic cardiomyopathy

Медицинский совет, 2021
Introduction. Hypertrophic cardiomyopathy is one of the most common diseases of the myocardium in children. Meanwhile, the relationship between indicators of strain and electrocardiographic changes, their diagnostic significance for children with ...
N. Yu. Chernykh, A. A. Tarasova, O. S. Groznova, I. M. Shigabeev   +3 more
doaj   +1 more source